Browse by author
Lookup NU author(s): Professor Marco Carrozzo
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.Targeted cancer therapies have fundamentally transformed the treatment of many types of cancers over the past decade, including breast, colorectal, lung, and pancreatic cancers, as well as lymphoma, leukemia, and multiple myeloma. The unique mechanisms of action of these agents have resulted in many patients experiencing enhanced tumor response together with a reduced adverse event profile as well. Toxicities do continue to occur, however, and in selected cases can be clinically challenging to manage. Of particular importance in the context of this monograph is that the pathobiology for oral mucosal lesions caused by targeted cancer therapies has only been preliminarily investigated. There is distinct need for novel basic, translational, and clinical research strategies to enhance design of preventive and therapeutic approaches for patients at risk for development of these lesions. The research modeling can be conceptually enhanced by extrapolating "lessons learned" from selected oral mucosal conditions in patients without cancer as well. This approach may permit determination of the extent to which pathobiology and clinical management are either similar to or uniquely distinct from oral mucosal lesions caused by targeted cancer therapies. Modeling associated with oral mucosal disease in non-oncology patients is thus presented in this context as well. This article addresses this emerging paradigm, with emphasis on current mechanistic modeling and clinical treatment. This approach is in turn designed to foster delineation of new research strategies, with the goal of enhancing cancer patient treatment in the future.
Author(s): Carrozzo M, Eriksen JG, Bensadoun R-J, Boers-Doets CB, Lalla RV, Peterson DE
Publication type: Article
Publication status: Published
Journal: Journal of the National Cancer Institute. Monographs
Year: 2019
Volume: 2019
Issue: 53
Print publication date: 19/08/2019
Online publication date: 19/08/2019
Acceptance date: 01/05/2019
ISSN (print): 1052-6773
ISSN (electronic): 1745-6614
Publisher: Oxford University Press
URL: https://doi.org/10.1093/jncimonographs/lgz012
DOI: 10.1093/jncimonographs/lgz012
PubMed id: 31425602
Altmetrics provided by Altmetric
